Dec. 20, 2018 3:52 PM
Hybrid Technology Hub researcher Jo Waaler is awarded a grant of 4,4 million NOK for the project Tankyrase Inhibition in Cancer Immunotherapy. The grant is awarded by Helse Sør Øst.
Nov. 5, 2018 3:02 PM
Ann Lin is a Fulbright scholar from the United States who joined the centre in August. At the Hybrid Technology Hub, Ann hopes to combine mass spectrometry technology, organoids, and organ-on-CHIP technology to create a pipeline to measure patient response to drugs.
Sep. 12, 2018 3:38 PM
Adipose derived stem cells (ASCs) are currently being investigated for a number of uses in regenerative medicine, but potential clinical use would require a robust method capable of producing a high number of cells.
In this article, Scholz Group member and PhD student Simen W. Schive et al. describe a method for large scale production of ASCs using automated systems, a workflow that could be used for future clinical trials. The manuscript was selected for the cover page in the current issue of CellR4.
June 13, 2018 10:10 AM
At the Oslo University Hospital, HTH researcher Dr. Hanne Scholz is testing 3D-printing technology in an attempt to cure patients with diabetes type 1.
Mar. 15, 2018 1:48 PM
The Steven Wilson and Stefan Krauss-led project, Organ-on-chip connected to mass spectrometry: An efficient tool for developing and testing drugs was awarded in the category for student-active research.
Mar. 13, 2018 2:37 PM
Jo Waaler and Stefan Krauss are one of six new SPARK teams at UiO: Life Sciences